ArticleScientific reports2024
The expression of different gene constructs in Escherichia coli SM lux biosensor after exposure to drugs.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Modulating effect of glutathione (GSH) on 2,4-dichlorophenoxyacetic acid (2,4-D) toxicity.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The research used bacterial biosensors containing bacterial luciferase genes to monitor changes in the environment in real-time. In this work to express four different gene constructs: recA:luxCDABE, soxS:luxCDABE, micF:luxCDABE, and rpoB:luxCDABE in Escherichia coli SM lux biosensor after exposure to three different antibiotics (nalidixic acid, ampicillin, kanamycin) and diclofenac was determined. It was found that incubation of the E. coli SM strain in various concentrations of analytes results in differentiation in gene expression at each of the tested concentrations (from 0.625 to 10 µg/mL) and during all three measurements, in "time 0", after 30 min. and after 1 h. The measurable signal is created as a result of the action of reporter genes (bacterial luciferase genes luxCDABE), present in genetically modified bacterial cells. E. coli luminescent bioreporters in the stationary phase were used. In the analysis of the induction of the promoter (regulatory proteins) to the control (0 µg/ml), the highest biosensor response was shown in the case of kanamycin concentration equal to 0.625 µg/mL after 1-h incubation. The highest increase express gene construct was found for micF:luxCDABE in E. coli SM343 lux biosensor, where the micF promoter induction relative to the control at a concentration of 0.625 µg/mL is 73.9%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.